| INFARMED [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | 神経学的
> 多発性硬化症 | 規制上のパートナーシップ
> 規制機関との連携 | 1,000 | National | Regularly | 115015053859 |
| We are partners in the Projeto Incluir [Inclusion Project] led by Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | がん
> がん：乳房 | 規制上のパートナーシップ
> 規制機関との連携 | 1,000 | Regional | Regularly | 115017018417 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | 難聴
> 難聴 | 規制上のパートナーシップ
> 規制機関との連携 | 100 | National | No | 115029020137 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | 脳血管
> ストローク | 規制上のパートナーシップ
> 規制機関との連携 | 5,000 | National | Regularly | 115032426383 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | 患者擁護
> 患者擁護 | 規制上のパートナーシップ
> 規制機関との連携 | 5,000 | National | Rarely | 115033491291 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | メンタルヘルス
> メンタルヘルス：ほとんどの状態 | 規制上のパートナーシップ
> 規制機関との連携 | 10,000 | National | Regularly | 115056273634 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | 患者擁護
> 患者擁護 | 規制上のパートナーシップ
> 医療技術評価（HTA）および償還審査への参加 | 5,000 | National | Rarely | 115033491291 |
| We occasionally receive a form through which we are invited to submit written contributions to HTA [Avaliação de Tecnologias de Saúde – Health Technology Assessment] processes. | リウマチ性
> リウマチ性疾患：ほとんどの種類 | 規制上のパートナーシップ
> 医療技術評価（HTA）および償還審査への参加 | 100 | National | Sometimes | 115060632863 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | 神経学的
> 多発性硬化症 | 規制上のパートナーシップ
> 医療技術評価（HTA）および償還審査への参加 | 5,000 | National | Regularly | 115060898897 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | 患者擁護
> 患者擁護 | 規制上のパートナーシップ
> マーケティング承認申請への貢献 | 5,000 | National | Rarely | 115033491291 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | 難聴
> 難聴 | 規制上のパートナーシップ
> 政策立案者・規制当局との会議への出席・ファシリテーション | 100 | National | No | 115029020137 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | 患者擁護
> 患者擁護 | 規制上のパートナーシップ
> 政策立案者・規制当局との会議への出席・ファシリテーション | 5,000 | National | Rarely | 115033491291 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | 神経学的
> 多発性硬化症 | 規制上のパートナーシップ
> 政策立案者・規制当局との会議への出席・ファシリテーション | 5,000 | National | Regularly | 115060898897 |
| Negotiation with the government or with parliamentary groups. | 全般的な健康状態
> 肥満 | 政策と法律への影響
> 医療政策と法律に影響を与える | 1,000 | National | Regularly | 115006675660 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | 呼吸器
> 喘息 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | Do not know | National | Sometimes | 115032964525 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | 呼吸器
> 喘息 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | Do not know | National | Sometimes | 115032964525 |
| 2023: meeting with the Parliamentary Health Group at the AR [Assembleia da República – Assembly of the Republic]. | 心臓血管
> 心臓・循環器系の疾患 | 政策と法律への影響
> 公聴会やパブリックコンサルテーションに参加する | 1,000 | National | Sometimes | 115054128784 |
| Negotiation with the government or with parliamentary groups. | 全般的な健康状態
> 肥満 | 政策と法律への影響
> 国会議員や政治指導者を動員する | 1,000 | National | Regularly | 115006675660 |
| Each year, we submit our advocacy document to the parliamentary groups. | 障害
> 障害：ほとんどの種類 | 政策と法律への影響
> 国会議員や政治指導者を動員する | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Through the Parliamentary Health Group. | 心臓血管
> 心臓・循環器系の疾患 | 政策と法律への影響
> 国会議員や政治指導者を動員する | 100 | National | Regularly | 115033109950 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | 障害
> 障害：ほとんどの種類 | 価格設定と手頃な価格の擁護
> 公正な医薬品価格の実現を推進する | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | 障害
> 障害：ほとんどの種類 | 価格設定と手頃な価格の擁護
> 低所得者や脆弱な立場にある人々のコスト面での障壁に対処する | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Active participation in discussions on access to PAP [Programas de Acesso Precoce – Early Access Programmes] and in the centralised funding of medicines intended for rare diseases. | 神経筋
> 神経筋疾患：ほとんどのタイプ | アクセス経路の改善
> 希少・超希少疾患治療へのアクセス改善 | 1,000 | National | Regularly | 115022855373 |
| Questionnaire for the collection of contributions from patient associations in the context of Health Technology Assessment [in Portugal]. | 消化器系
> 消化器系：その他 | エビデンスに基づく患者の意見
> 調査/研究を実施してデータを生成する | 1,000 | National | Sometimes | 114997613546 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | 呼吸器
> 喘息 | エビデンスに基づく患者の意見
> 調査/研究を実施してデータを生成する | Do not know | National | Sometimes | 115032964525 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | 脳血管
> ストローク | 機関ガバナンス
> 政府の諮問機関における代表性を確保する | 5,000 | National | Regularly | 115032426383 |
| Projeto Incluir [The project establishes a formal mechanism for patient rights and civic participation in Portugal. It allows patients and their advocacy organizations to have an active voice in Health Technology Assessment (HTA), Medicine Shortages & Safety and Policy Representation: Acting as a bridge between policymakers and citizens, ensuring that healthcare decisions account for patient values and experiences.] | 患者擁護
> 患者の権利 | 機関ガバナンス
> 政府の諮問機関における代表性を確保する | 5,000 | National | Regularly | 115042989304 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | メンタルヘルス
> メンタルヘルス：ほとんどの状態 | 機関ガバナンス
> 政府の諮問機関における代表性を確保する | 10,000 | National | Regularly | 115056273634 |
| Through the Parliamentary Health Group. | 心臓血管
> 心臓・循環器系の疾患 | 機関ガバナンス
> マルチステークホルダーネットワーク内での効果的な協働 | 100 | National | Regularly | 115033109950 |
インタラクション
アクションと支援活動
13 メンション
